Actions of methylpheniclate on dopaminergic neurons of the ventral midbrain

被引:45
作者
Federici, M
Geracitano, R
Bernardi, G
Mercuri, NB
机构
[1] IRCCS, Fdn Santa Lucis, Lab Expt Neurol, I-00179 Rome, Italy
[2] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy
关键词
ADHD; methylphenidate; dopamine; DAT; ventral midbrain; synaptic transmission;
D O I
10.1016/j.biopsych.2004.11.030
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Methylphenidate has been suggested to exert its therapeutic mainly byh blocking the dopamine transporter. In spite of the importance of this interaction, no detailed information is available yet on its actions on single dopaminergic neurons. Methods. We examined the effects of methylphenidate on dopaminergic neurons using electrophysiological recordings from rat midbrain slices. Results: Methylphenidate inhibited spontaneous firing and caused a membrane hyperpolarization in current clamp or an outward current in voltage clamp. These effects were antagonized by the D-2 receptor antagonist sulpiride. An acute dopamine-depleting treatment of the slices with the dopa-decarboxylase inhibitor carbidopa significantly reduced the effects of methylphenidate. This drug potentiated, in a concentration-dependent manner, cellular responses to exogenous dopamine application, Conclusions: Our electrophysiological data are consistent with the hypothesis that methylphenidate inhibits dopamine transporter and suggest that the depression of firing is mediated by the release of newly synthesized dopamine which accumulates extracellularly due to inhibition of its reuptake.
引用
收藏
页码:361 / 365
页数:5
相关论文
共 41 条
  • [31] Drugs used in the treatment of attention-deficit/hyperactivity disorder affect postsynaptic firing rate and oscillation without preferential dopamine autoreceptor action
    Ruskin, DN
    Bergstrom, DA
    Shenker, A
    Freeman, LE
    Baek, D
    Walters, JR
    [J]. BIOLOGICAL PSYCHIATRY, 2001, 49 (04) : 340 - 350
  • [32] Sandoval V, 2002, J NEUROSCI, V22, P8705
  • [33] Segal DS, 1999, J PHARMACOL EXP THER, V291, P19
  • [34] SENSITIZATION OF MICE TO METHYLPHENIDATE
    SHUSTER, L
    HUDSON, J
    ANTON, M
    RIGHI, D
    [J]. PSYCHOPHARMACOLOGY, 1982, 77 (01) : 31 - 36
  • [35] RATE OF BINDING OF VARIOUS INHIBITORS AT THE DOPAMINE TRANSPORTER IN-VIVO
    STATHIS, M
    SCHEFFEL, U
    LEVER, SZ
    BOJA, JW
    CARROLL, FI
    KUHAR, MJ
    [J]. PSYCHOPHARMACOLOGY, 1995, 119 (04) : 376 - 384
  • [36] Serum and brain concentrations of methylphenidate: implications for use and abuse
    Swanson, JM
    Volkow, ND
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2003, 27 (07) : 615 - 621
  • [37] Volkow N D, 2002, J Atten Disord, V6 Suppl 1, pS31
  • [38] Volkow N D, 2001, J Neurosci, V21, pRC121
  • [39] Volkow ND, 1999, J PHARMACOL EXP THER, V288, P14
  • [40] Effects of methylphenidate analogues on phenethylamine substrates for the striatal dopamine transporter: Potential as amphetamine antagonists?
    Wayment, HK
    Deutsch, H
    Schweri, MM
    Schenk, JO
    [J]. JOURNAL OF NEUROCHEMISTRY, 1999, 72 (03) : 1266 - 1274